115 related articles for article (PubMed ID: 7453846)
1. Potential anticancer agents. XX. 1. Steric fit analysis in aromatic nitrogen mustards area.
Bădilescu II; Crăescu T; Niculescu-Duvăz I; Simon Z
Neoplasma; 1980; 27(3):261-9. PubMed ID: 7453846
[TBL] [Abstract][Full Text] [Related]
2. Potential anticancer agents. XX. 2. Quantitative structure--activity relationships (QSAR) in aromatic nitrogen mustards area.
Niculescu-Duvăz I; Stihi G; Crăescu T; Simon Z
Neoplasma; 1980; 27(3):271-8. PubMed ID: 7453847
[TBL] [Abstract][Full Text] [Related]
3. Potential anticancer agents. XVII. New developments in the benzoic acid nitrogen mustards area.
Niculescu-Duvăz I; Feyns V; Dobre V
Cancer Treat Rep; 1978 Dec; 62(12):2045-54. PubMed ID: 751714
[TBL] [Abstract][Full Text] [Related]
4. [Tumour chemotherapy: syntheses of N-phosphorylated nitrogen mustards and related compounds].
Kao WI; Ho HY; Song CW; Li MM; Cheng BL
Yao Xue Xue Bao; 1965 Oct; 12(10):672-7. PubMed ID: 5898992
[No Abstract] [Full Text] [Related]
5. [Antitumor action of phenylalanine derivatives of mechlorethamine (author's transl)].
Zhou JX; Liang HZ; Xu B
Zhongguo Yao Li Xue Bao; 1981 Jun; 2(2):121-8. PubMed ID: 6461211
[No Abstract] [Full Text] [Related]
6. A mitomycin C-resistant Jensen rat sarcoma: chemotherapy studies.
Sugiura K; Merker PC
Cancer Res; 1963 Sep; 23(8 Pt 2):1475-82. PubMed ID: 5878213
[No Abstract] [Full Text] [Related]
7. Significant differences in biological parameters between prodrugs cleavable by carboxypeptidase G2 that generate 3,5-difluoro-phenol and -aniline nitrogen mustards in gene-directed enzyme prodrug therapy systems.
Niculescu-Duvaz I; Scanlon I; Niculescu-Duvaz D; Friedlos F; Martin J; Marais R; Springer CJ
J Med Chem; 2004 May; 47(10):2651-8. PubMed ID: 15115406
[TBL] [Abstract][Full Text] [Related]
8. 3D QSAR/CoMFA and CoMSIA studies on antileukemic steroidal esters coupled with conformationally flexible nitrogen mustards.
Kapou A; Benetis NP; Durdagi S; Nikolaropoulos S; Mavromoustakos T
J Chem Inf Model; 2008 Nov; 48(11):2254-64. PubMed ID: 18954137
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationship of a series of nitrogen mustard- and pyrrole-containing minor groove-binding agents related to distamycin.
Wyatt MD; Garbiras BJ; Haskell MK; Lee M; Souhami RL; Hartley JA
Anticancer Drug Des; 1994 Dec; 9(6):511-25. PubMed ID: 7880376
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and structure-activity relationships for 2,4-dinitrobenzamide-5-mustards as prodrugs for the Escherichia coli nfsB nitroreductase in gene therapy.
Atwell GJ; Yang S; Pruijn FB; Pullen SM; Hogg A; Patterson AV; Wilson WR; Denny WA
J Med Chem; 2007 Mar; 50(6):1197-212. PubMed ID: 17326614
[TBL] [Abstract][Full Text] [Related]
11. Anticancer potentiality of three new synthetic nitrogen mustards.
Téllez-Martínez J; García-Cavazos R; Yáñez R; González-Diddi M
Arch Invest Med (Mex); 1983; 14(2):159-71. PubMed ID: 6639257
[No Abstract] [Full Text] [Related]
12. Antileukemic and cytogenetic activity by triple administration of three modified steroidal derivatives of nitrogen mustards.
Fousteris MA; Papageorgiou A; Arsenou ES; Koutsourea AI; Karaberis E; Mourelatos D; Onyango DO; Nikolaropoulos SS
Chemotherapy; 2007; 53(2):118-26. PubMed ID: 17308378
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of cyclic nitrogen mustards based on carnitine framework.
Leiris S; Lucas M; Dupuy d'Angeac A; Morère A
Eur J Med Chem; 2010 Sep; 45(9):4140-8. PubMed ID: 20615582
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of substituted naphthalimide nitrogen mustards as rationally designed anticancer compounds.
Pain A; Samanta S; Dutta S; Saxena AK; Shanmugavel M; Kampasi H; Quazi GN; Sanyal U
Acta Pol Pharm; 2003; 60(4):285-91. PubMed ID: 14714857
[TBL] [Abstract][Full Text] [Related]
15. Potential anticancer agents. I. A nitrogen mustard based on orotic acid.
Danielsson B; Bogentoft C; Ljungnér F
Acta Pharm Suec; 1968 Sep; 5(4):279-82. PubMed ID: 5724370
[No Abstract] [Full Text] [Related]
16. [Effect of serotonin on the antineoplastic activity and toxicity of sarcolysin and dopan].
Mal'tseva LF
Farmakol Toksikol; 1966; 29(6):698-701. PubMed ID: 6000367
[No Abstract] [Full Text] [Related]
17. Bis(dialkyl)dithiocarbamato cobalt(III) complexes of bidentate nitrogen mustards: synthesis, reduction chemistry and biological evaluation as hypoxia-selective cytotoxins.
Ware DC; Palmer HR; Pruijn FB; Anderson RF; Brothers PJ; Denny WA; Wilson WR
Anticancer Drug Des; 1998 Mar; 13(2):81-103. PubMed ID: 9524553
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationship of aniline mustards acting against B-16 melanoma in mice.
Panthananickal A; Hansch C; Leo A
J Med Chem; 1979 Oct; 22(10):1267-9. PubMed ID: 513075
[TBL] [Abstract][Full Text] [Related]
19. Selective cytotoxicity of haloethylnitrosoureas in a carcinoma cell line resistant to bifunctional nitrogen mustards.
Tew KD; Wang AL
Mol Pharmacol; 1982 May; 21(3):729-38. PubMed ID: 7110120
[TBL] [Abstract][Full Text] [Related]
20. Derivatives of fluorene. XXII. Nitrogen mustards. II.
Fletcher TL; Wetzel WH; Namkung MJ
J Med Chem; 1966 Jul; 9(4):593-8. PubMed ID: 5968030
[No Abstract] [Full Text] [Related]
[Next] [New Search]
